Congenital myasthenic syndrome due to a TOR1AIP1 mutation: a new disease pathway for impaired synaptic transmission. (2020)
Attributed to:
Disease mechanisms and therapy for inherited disorders of the neuromuscular synapse.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/braincomms/fcaa174
PubMed Identifier: 33215087
Publication URI: http://europepmc.org/abstract/MED/33215087
Type: Journal Article/Review
Volume: 2
Parent Publication: Brain communications
Issue: 2
ISSN: 2632-1297